Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Tiny protein prevents disease-related cell death

12.05.2003


Tiny protein targets Bax, inhibits apoptosis



Researchers at The Burnham Institute have found that humanin, a small, 24-amino acid protein recently discovered in studies of Alzheimer’s Disease, suppresses activation of the protein Bax. Bax triggers pathologic cell death in a number of diseases, including Parkinson’s, stroke, heart attack and degeneration of ovaries during menopause. These results, to be published later this month in the journal Nature (currently available at the journal’s website), suggest a novel target for therapeutic design based on inhibiting the cell destructive activity of Bax.

Bax protein is known to promote the cell death program (also known as apoptosis) latent in all cells. It does so by attacking the cell’s powerhouse, called “mitochondria”, resulting in the cell’s demise. Apoptosis is critical for normal development and maintaining cell balance. Many diseases are identified with malfunction of apoptosis: too much cell death is associated with degenerative diseases of the nervous system, stroke and heart attack; failure to activate the cell death program is one of the hallmarks of cancer.


Dr. Reed’s laboratory identified humanin as a Bax-interactive protein. In the current study, they showed that humanin bound to Bax, which prevented its targeting to mitochondria and blocked its ability to cause cell death.

“Our results demonstrate that Bax is the target of humanin, and they suggest at least three novel ways of designing therapeutics that could prevent or arrest diseases associated with activation of Bax,” says Dr. Reed.

Dr. Reed envisions that the tiny protein humanin could be synthesized and developed as an injectable drug for acute situations, such as heart attack or stroke, because humanin has the unique ability to readily enter cells. Gene therapy that exploits humanin’s ability to translocate from cell to cell could also be developed to protect cells in the vicinity of the gene’s injection, such as the heart or certain regions of the brain. Structural information about humanin could be used to pattern chemicals developed into pill form, for more convenient administration protecting against pathological cell death.



Dr. Reed is President and CEO of The Burnham Institute, and Professor in the Institute’s Del E. Webb Center for Neuroscience and Aging Research and in the Cancer Center.

Co-author Arnold Satterthwait, Ph.D., Burnham Institute Professor, synthesized peptides used in this study.

This research was supported by grants from the National Institutes of Health, and the Department of Defense.

The Burnham Institute is an independent, nonprofit, public benefit organization dedicated to basic biomedical research principally in the areas of cancer, aging, and the neurosciences. The Institute ranks consistently among the world’s most influential research organizations for the impact of its research in analyses conducted annually by the Institute for Scientific Information.

Nancy Beddingfield | EurekAlert!
Further information:
http://www.burnham-inst.org/

More articles from Health and Medicine:

nachricht The genes are not to blame
20.07.2018 | Technische Universität München

nachricht Targeting headaches and tumors with nano-submarines
20.07.2018 | Universitätsmedizin der Johannes Gutenberg-Universität Mainz

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Future electronic components to be printed like newspapers

A new manufacturing technique uses a process similar to newspaper printing to form smoother and more flexible metals for making ultrafast electronic devices.

The low-cost process, developed by Purdue University researchers, combines tools already used in industry for manufacturing metals on a large scale, but uses...

Im Focus: First evidence on the source of extragalactic particles

For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.

To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...

Im Focus: Magnetic vortices: Two independent magnetic skyrmion phases discovered in a single material

For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.

Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...

Im Focus: Breaking the bond: To take part or not?

Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.

A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...

Im Focus: New 2D Spectroscopy Methods

Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.

"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Leading experts in Diabetes, Metabolism and Biomedical Engineering discuss Precision Medicine

13.07.2018 | Event News

Conference on Laser Polishing – LaP: Fine Tuning for Surfaces

12.07.2018 | Event News

11th European Wood-based Panel Symposium 2018: Meeting point for the wood-based materials industry

03.07.2018 | Event News

 
Latest News

A smart safe rechargeable zinc ion battery based on sol-gel transition electrolytes

20.07.2018 | Power and Electrical Engineering

Reversing cause and effect is no trouble for quantum computers

20.07.2018 | Information Technology

Princeton-UPenn research team finds physics treasure hidden in a wallpaper pattern

20.07.2018 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>